-
Track & Monitor
Immuno-oncology in Pharmaceuticals: Genetic engineered chimeric antibodies
Innovation in the pharmaceuticals industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts, posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in pharmaceuticals industry. Using patents data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating...
-
Track & Monitor
Innovation in Pharmaceuticals: Genetically modified fusion polypeptides
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the Pharmaceuticals industry’s Genetically modified fusion polypeptides segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered...
-
Product Insights
Retrovirus Tests – Medical Devices Pipeline Assessment, 2020
Retrovirus Tests are the diagnostic tests used to detect the antigen/antibody of HIV1, HIV 2 (human immunodeficiency virus) and HTLV I, HTLV II (human T-cell lymphotropic virus) viruses. GlobalData's Medical Devices sector report, “Retrovirus Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Retrovirus Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Retrovirus Tests Pipeline Assessment report provides key information and data...
-
Product Insights
Parasitology and Mycology Rapid Tests and POC – Medical Devices Pipeline Assessment, 2020
Parasitology & Mycology Rapid Tests & POC comprises of rapid test kits intended for rapid diagnosis, with immediate results, through immuno assays for the detection of pathogenic protozoans and fungi. GlobalData's Medical Devices sector report, “Parasitology & Mycology Rapid Tests & POC-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Parasitology & Mycology Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in...
-
Sector Analysis
United States In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others
GlobalData’s “United States In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United States In Vitro Diagnostics Market report provides key information and data on: • Annualized market...